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Table 1. Top 3 greatest challenges facingBMTnurses in today’s
healthcare environment (N 5 148)
Challenges
First
Choice
Second
Choice
Third
Choice
Weighted
Rank Score
Recruiting/hiring nurses 28% 12% 13% 59
Education/orientation of
new nurses
15% 21% 12% -
Staying abreast of scientific
advances in BMT
22% 25% 12% 63
Working in challenging/stressful
environment
56% 24% 8% 111
Meeting patients’ needs 18% 20% 17% -
Balancing demands of
work/personal life
20% 20% 19% 59
Resources for addressing
ethical/moral issues in BMT
12% 22% 20% -
TheWeighted Rank Score is equal to the sum of points for first, second
and third choice designations (first 5 1.00 point; second 5 0.66 point;
and third 5 0.33 point).
S242 Oral Presentationstherapy when given every 6 hours, requiring prophylaxis with
phenytoin. From 2003 to date, at Children’s Memorial Hospital
(CMH) we have a RIC regimen utilizing ODD targeted BU for
two days. In this protocol, the seizure prophylaxis has been low
ODD Lo (0.05mg/kg max 2mg) since 2005. A 0.8 mg/kg test
dose (TD) of BU infused over 3 hours is given 5-7 days prior to
the RIC. Pharmacokinetic data from blood samples during the
TD BU provided information on AUC and clearance. The
AUC from the TD BU is used to calculate the ODD of BU.
The ODD BU is infused over 3 hours on day -5 and -4 of the
HSCT. To determine if ODD Lo prophylaxis for RIC BU was
associated with a low incidence of seizures, a retrospective chart
review was preformed of 68 pediatric patients from CMH. These
patients were a subset of a prospective study of RIC (IV BU x 2
days, Fludarabine 30 mg/m2 x 5 days, 6 ATG/ECP) for HSCT
carried out between July 2003 and May 2008. 50 patients (1
month-21 years of age) received ODD Lo as seizure prophylaxis
prior to ODD BU. The average ODD BU AUC per day was
3126 umol/min (2912-7254) and the average daily dose was 3.3
mg/kg. These patients had no history of seizures and were on
no other anti-epileptic medications. No patients experienced a sei-
zure during their RIC utilizing ODD Lo prophylaxis. Indication
for HSCT was malignancy in 20 patients and non-malignant dis-
ease in 30 patients. This low dose/frequency approach to seizure
prophylaxis was not associated with an increased risk of seizures.
ODD Lo is a low cost option for seizure prophylaxis in ODD BU
RIC regimens and is aimed at limiting the sedation associated
with Lo while providing coverage during the time period BU is
highly detectable in the blood allowing for a better quality of
life for the patients, especially since many of the RIC HSCTs
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Annually, more than 20,000 blood and marrow transplants
(BMT) are performed in the U.S. and this number is expected to
increase. Challenges to the future growth of BMT stem from the
projected nursing shortage, as identified in the 2010 IOM Report
on The Future of Nursing. The National Marrow Donor Pro-
gram sponsored the System Capacity Initiative (SCI) to assess
the ability to meet the increasing demand for BMT. The SCI con-
vened the Nursing Workforce Working Group (WG) which iden-
tified two priority challenges. The first is recruitment of BMT
nurses and the second is retention of nurses currently working in
the field.
Surveys were administered to members of the Oncology Nursing
Society and American Society of Blood andMarrowTransplantation
BMT nursing special interest groups between July and August 2010;
BMT nurses were also surveyed at the 2011 BMTTandemMeetings
(N 5 205). The survey objectives included:
– Characterize the current capacity of the U.S. BMT nursing
workforce
– Identify pathways through which nurses learned of and entered
the BMT specialty
– Assess satisfaction with the BMT specialty among nurses.
The survey was sent to an estimated 1,600 BMT nurses with
a response rate of 13% (N 5 205). Among respondents, 67% in-
dicated that their institution was planning to increase the numberof transplants performed annually. Respondents identified the
greatest challenges facing the BMT Nursing Workforce (Table 1).
In the next 5 years, many BMT nurses plan to advance their
level of nursing degree (66%); change roles within BMT (48%); re-
duce the number of hours worked (36%); and change specialties
(22%).
Based on survey results, the WG initiated programs to pro-
mote BMT nursing as a career choice and to identify stressors
and challenges in BMT nurses’ work environments that contrib-
ute to compassion fatigue and job attrition. Interest in exposing
nursing students to BMT was explored via interview at Loma
Linda Hospital and School of Nursing. An Introduction to
BMT outreach presentation was developed, targeting BSN
students.
The WG will continue to develop strategies to overcome recruit-
ment and retention challenges by developing an interdisciplinary
rounds model to address moral distress and compassion fatigue
among BMT nurses and targeted messaging for outreach to diverse
nursing communities of interest.105
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Allogeneic donor safety remains a primary cornerstone of the
UNC Bone Marrow and Stem Cell Transplant Quality Manage-
ment Program (QMP). Requirements for the safety of the do-
nor, recipient and the cellular therapy product are detailed in
the FACT Cellular Therapy Standards and the FDA’s Good
Tissue Practice Act. To insure compliance with regulations
and donor safety, continually evaluating the care delivered to re-
lated donors is a high-priority quality initiative for our program.
During 2009-2011, our QMP audited all related donor charts
for compliance of the following: review of the health history
questionnaire, pertinent positives noted in the donor’s medical
record (MR), and required laboratory evaluations. Audits also
assessed for documentation of the physical exam, assessment
of venous access, donor’s signature on the ‘‘Release of Medical
Records’’ form, pregnancy assessment, donor eligibility in the
donor and recipient’s MR, and review of abnormal results
with the donor including follow-up recommendations. Audits
were performed biannually in 2009 and 2010 and quarterly
in 2011. Data is presented in aggregate for each year. 62
